| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
| mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |